LeonaBio (LONA) Accounts Payables (2019 - 2026)
LeonaBio (LONA) reported Accounts Payables of $1.8 million for Q1 2026, up 103.46% year-over-year from $867000.0 in Q1 2025, and down 61.54% quarter-over-quarter from $4.6 million in Q4 2025.
LeonaBio (LONA) Accounts Payables (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Accounts Payables data on file, last reported at $1.8 million in Q1 2026.
- Accounts Payables for Q1 2026 came in at $1.8 million, up 103.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 103.46% YoY), and the FY2025 annual result was $4.6 million, up 1337.93% from the prior year.
- Accounts Payables declined to $1.8 million in Q1 2026 per LONA's latest filing, from $4.6 million in the prior quarter.
- Over five years, Accounts Payables peaked at $4.6 million in Q4 2025 and troughed at $129000.0 in Q4 2023.
- A 5-year average of $1.1 million and a median of $681000.0 in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables tumbled 94.84% in 2023, then surged 1337.93% in 2025.
- A 5-year view of Accounts Payables shows it stood at $2.5 million in 2022, then plunged by 94.84% to $129000.0 in 2023, then soared by 147.29% to $319000.0 in 2024, then surged by 1337.93% to $4.6 million in 2025, then plunged by 61.54% to $1.8 million in 2026.
- Business Quant data shows LONA's Accounts Payables at $1.8 million in Q1 2026, $4.6 million in Q4 2025, and $266000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | 266,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 319,000.00 |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 681,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 612,000.00 |
| Mar 31, 2023 | 892,000.00 |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 751,000.00 |
| Jun 30, 2022 | 605,000.00 |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 567,000.00 |
| Sep 30, 2021 | 959,000.00 |
| Jun 30, 2021 | 1.17 Mn |